Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
866.67M | 764.38M | 684.26M | 648.07M | 508.84M | Gross Profit |
234.62M | 218.94M | 244.19M | 224.28M | 166.54M | EBIT |
-73.26M | -82.06M | -17.72M | 37.97M | -23.71M | EBITDA |
-35.72M | -46.04M | 658.00K | 81.80M | 108.73M | Net Income Common Stockholders |
-93.46M | -104.75M | -75.33M | -65.20M | -29.40M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
52.50M | 44.32M | 71.88M | 80.57M | 258.84M | Total Assets |
793.84M | 810.91M | 977.31M | 1.29B | 1.53B | Total Debt |
456.40M | 451.27M | 512.44M | 565.59M | 690.74M | Net Debt |
403.90M | 406.95M | 440.56M | 485.02M | 431.90M | Total Liabilities |
579.32M | 588.35M | 650.00M | 887.41M | 1.06B | Stockholders Equity |
214.52M | 222.56M | 327.31M | 402.64M | 467.84M |
Cash Flow | Free Cash Flow | |||
0.00 | 55.42M | -4.98M | -156.86M | -21.57M | Operating Cash Flow |
0.00 | 88.64M | 15.46M | -135.29M | -12.47M | Investing Cash Flow |
0.00 | -32.89M | 55.94M | 113.42M | 300.93M | Financing Cash Flow |
0.00 | -83.31M | -80.09M | -156.41M | -54.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
65 Neutral | $8.81B | 14.92 | 4.67% | 6.17% | 3.60% | -2.89% | |
39 Underperform | HK$550.41M | ― | -42.82% | ― | 10.98% | 29.31% | |
$24.57B | 6.17 | 9.66% | 1.41% | ― | ― | ||
$66.68B | 35.15 | 27.96% | 2.50% | ― | ― | ||
$135.18M | ― | -20.26% | ― | ― | ― | ||
54 Neutral | HK$982.71M | 13.49 | 2.75% | 3.57% | -11.89% | -69.45% | |
39 Underperform | HK$441.97M | ― | -69.34% | ― | ― | ― |
Labixiaoxin Snacks Group Ltd. has announced its upcoming annual general meeting scheduled for June 19, 2025, in Hong Kong. Key agenda items include the adoption of financial statements for 2024, re-election of directors, and authorization for the board to fix remuneration for directors and auditors. The meeting will also consider resolutions to empower directors to manage share-related activities, which could impact the company’s capital structure and shareholder value.
Labixiaoxin Snacks Group Ltd. reported its annual financial results for the year ending December 31, 2024, showing a 13.4% increase in revenue to RMB 866.7 million. Despite the revenue growth, the company faced a net loss of RMB 93.5 million, a decrease from the previous year’s loss. The gross profit margin slightly declined to 27.1%, and the return on equity worsened to -41.7%. These results indicate ongoing financial challenges and may impact the company’s market positioning and stakeholder confidence.
Labixiaoxin Snacks Group Ltd. has announced a board meeting scheduled for March 28, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the recommendation for a final dividend payment, which could impact shareholder returns and reflect the company’s financial health.